NEWS: In the last 24 hours, at least two abortion clinics/networks (Trust Women + Whole Womans Health) have announced that they will NOT immediately stop prescribing mifepristone if the judge rules to suspend or withdraw FDA approval. They will await a directive from the FDA.

U.S. District Court judge rules to revoke FDA approval of abortion pill
Abortion Pill·By Nancy Flanders
U.S. District Court judge rules to revoke FDA approval of abortion pill
UPDATE, 4/10/23: The Biden administration DOJ filed a notice of appeal to the Fifth Circuit the same day that Judge Kacsmaryk released his decision, and today officially filed its appeal, asking that the district court’s decision be kept on hold until the Fifth Circuit decides the case.
4/7/23: District Court Judge Matthew J. Kacsmaryk ruled today to overturn the Food and Drug Administration’s (FDA) approval of mifepristone, the abortion drug that was approved for use in the United States in 2000. The FDA is likely to appeal the decision. Kacsmaryk gave a week for the order to take effect, giving the Biden administration that time to file an appeal.
The ruling means that mifepristone, the first drug of the abortion pill regimen, no longer has FDA approval and could result in a new FDA review of mifepristone. In anticipation of this ruling, the abortion industry has been planning to move to a misoprostol-only abortion method that carries a high failure rate. However, some abortion businesses, including Whole Women’s Health, have announced they “will not immediately stop prescribing mifepristone” based on Kacsmaryk’s ruling.
Misoprostol is the second drug in the current abortion pill regimen. While the first drug, mifepristone, acts to block the naturally occurring hormone progesterone (depriving the child of nutrients needed to grow), misoprostol causes contractions that expel the baby from the uterus.
“The U.S. Food and Drug Administration chose politics over science when it pushed for the legalization of the chemical abortion drugs mifepristone and misoprostol in 2000,” said Alliance Defending Freedom (ADF), the legal team representing the Alliance for Hippocratic Medicine, the American Association of Pro-Life Obstetricians and Gynecologists, the American College of Pediatricians, the Christian Medical & Dental Associations, and others in the lawsuit brought against the FDA in November.
“The only way the FDA was able to approve the drugs was by characterizing pregnancy as an ‘illness’ and arguing that these drugs provide a ‘meaningful therapeutic benefit.’ As the medical groups and doctors filing suit explain, by approving chemical abortion drugs, the FDA failed to abide by its legal obligations to protect the health, safety, and welfare of girls and women,” ADF added. “The FDA never studied the safety of the drugs under the labeled conditions of use, ignored the potential impacts of the hormone-blocking regimen on the developing bodies of adolescent girls, disregarded the substantial evidence that chemical abortion drugs cause more complications than surgical abortions, and eliminated necessary safeguards for pregnant girls and women who undergo this dangerous drug regimen.”
Article continues below
Dear Reader,
Have you ever wanted to share the miracle of human development with little ones? Live Action is proud to present the "Baby Olivia" board book, which presents the content of Live Action's "Baby Olivia" fetal development video in a fun, new format. It's perfect for helping little minds understand the complex and beautiful process of human development in the womb.
Receive our brand new Baby Olivia board book when you give a one-time gift of $30 or more (or begin a new monthly gift of $15 or more).

In addition to approving the drugs on “shaky legal and moral ground,” as explained by ADF Senior Counsel Erik Baptist, the FDA has had “years of evading responsibility….”
In 2016, the FDA extended the gestational age of the baby that can legally be killed by the abortion pill from seven weeks’ gestation to 10 weeks gestation. This puts women at a greater risk of complications from the already dangerous abortion pill regimen as abortion grows riskier with each week of pregnancy. The FDA at that time also changed the dosage and administration method of the abortion pill, reduced the required in-person doctor’s visits for taking the abortion pill from three to one, and allowed non-physicians to prescribe and administer mifepristone. In addition, the FDA told abortionists they no longer had to report any non-fatal complications from the abortion pill to the manufacturer, thereby helping to hide the complications that did result from the reduced FDA
protections.
Then in 2021, the Biden FDA decided that the abortion drugs could be sent through the mail — a direct violation of federal law. In 2023, the FDA announced its decision to allow retail pharmacies to become distributors of the abortion pill regimen.

“Over twenty years ago, the FDA caved to pressure from the abortion lobby and neglected the health and safety of women and children to approve the distribution of mifepristone, whose intended use is to starve a living child,” said Live Action founder and president Lila Rose. “This deadly drug is approved for use up through ten weeks of pregnancy, at which point a human child has arms, eyelids, fingers, toes, and organs. These children have beating hearts, and if they were not intentionally killed, they would live. In combination with misoprostol, the abortion pill regimen accounts for over half of all abortions in the United States.”
She added, “Health care heals. It does not kill. The FDA’s decision to approve the chemical abortion pill was egregiously wrong from the outset and has been a grave wound in the soul of our country. This ruling is a huge step towards protecting women and their unborn children, but the battle does not end here. We expect that this decision will be appealed by abortion advocates and may ultimately make its way to the Supreme Court.”
Live Action News is pro-life news and commentary from a pro-life perspective.
Contact editor@liveaction.org for questions, corrections, or if you are seeking permission to reprint any Live Action News content.
Guest Articles: To submit a guest article to Live Action News, email editor@liveaction.org with an attached Word document of 800-1000 words. Please also attach any photos relevant to your submission if applicable. If your submission is accepted for publication, you will be notified within three weeks. Guest articles are not compensated (see our Open License Agreement). Thank you for your interest in Live Action News!
Read Next

Full term 'miracle' baby born after 'unprecedented' ectopic pregnancy
Bridget Sielicki
·More In Abortion Pill

Abortion Pill
Florida and Texas re-file lawsuit challenging abortion pill
Carole Novielli
·
Abortion Pill
South Dakota AG tells abortion pill advertiser to 'cease and desist'
Bridget Sielicki
·
Abortion Pill
FDA Commissioner accused of intentionally delaying abortion pill safety review
Carole Novielli
·
Abortion Pill
Ohio doctor charged with six felonies for forcing abortion pill on woman
Bridget Sielicki
·
Abortion Pill
Law prohibiting distribution of abortion pill in Texas takes effect
Bridget Sielicki
·More From Nancy Flanders

Issues
Annual report shows increase in Canada's assisted deaths
Nancy Flanders
·
Human Interest
Pro-life nuns send annual Christmas cards to abortion businesses across the US
Nancy Flanders
·
Investigative
Worker finds deceased 27-week baby inside San Diego porta-potty
Nancy Flanders
·
Pop Culture
Pro-abortion critics slam Gwen Stefani for partnering with Catholic Hallow app
Nancy Flanders
·
Human Interest
Twin born at 23 weeks fought to survive after brother's death
Nancy Flanders
·